The real worth of cancer drugs

1 December 2020 - In November, 2020, we witnessed one of the most awaited elections in recent times—the USA elected Joe ...

Read more →

Outraged patients to present petition with over 30,000 signatures to ask for funding for desperately needed medication

2 December 2020 - Sick of waiting for years for PHARMAC to fund standard, current therapy to treat their diseases, ...

Read more →

US hopeful of pre-Christmas COVID jab, Australia still has long wait

1 December 2020 - Millions of vulnerable Americans could be vaccinated against coronavirus before the end of 2020 but it ...

Read more →

FDA approves pralsetinib for RET altered thyroid cancers

1 December 2020 - Today the Food and Drug Administration approved pralsetinib (Gavreto, Blueprint Medicines) for adult and pediatric patients ...

Read more →

EMA receives application for conditional marketing authorisation of COVID-19 mRNA vaccine BNT162b2

1 December 2020 - EMA has received an application for conditional marketing authorisation for BNT162b2, a COVID‑19 mRNA vaccine developed by ...

Read more →

FDA approves first PSMA-targeted PET imaging drug for men with prostate cancer

1 December 2020 - Today, the U.S. FDA approved Gallium 68 PSMA-11 (Ga 68 PSMA-11) – the first drug for ...

Read more →

EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine

1 December 2020 - EMA has received an application for conditional marketing authorisation for a COVID-19 mRNA vaccine by Moderna Biotech. ...

Read more →

Innovative technology to detect abnormal heart rhythms recommended by NICE for NHS use while further data is collected

1 December 2020 - Zio ZT is the first assessment, via the NICE digital health technologies guidance development pilot project, to ...

Read more →

Mirum Pharmaceuticals announces European Medicines Agency validation of the marketing authorisation application for maralixibat in patients with PFIC2

30 November 2020 - Five-year transplant-free survival data from the Phase 2 INDIGO study used as the basis for the MAA ...

Read more →

ARS announces acceptance of market authorisation application submission to European Medicines Agency for Neffy (ARS-1; epinephrine nasal spray)

30 November 2020 - ARS Pharmaceuticals announced today that the EMA has accepted a marketing authorisation application submission for review of ...

Read more →

Kadmon announces FDA acceptance of NDA for belumosudil in patients with chronic graft versus host disease

30 November 2020 - Application being evaluated Under FDA's Real-Time Oncology Review and Project Orbis pilot programs. ...

Read more →

ICER releases draft evidence report on therapies for anaemia in chronic kidney disease

30 November 2020 - Public comment period now open until 5 January 2021; requests to make oral comment during public meeting ...

Read more →

Karolinska Development's portfolio company Aprea Therapeutics receives FDA fast track designation for eprenetapopt in AML

30 November 2020 - Karolinska Development announces today that the U.S. FDA has granted fast track designation for eprenetapopt in the ...

Read more →

Now more than ever, the fight against HIV must continue

1 December 2020 - To mark World AIDS Day 2020 and support the ‘now more than ever’ theme, the Morrison Government ...

Read more →

Astellas receives approval of Evrenzo (roxadustat) in Japan for the treatment of anaemia of chronic kidney disease in adult patients not on dialysis

27 November 2020 - Approval by MHLW provides new HIF-PH inhibitor treatment option for healthcare providers and adult patients with ...

Read more →

Canada to Trump: you can't take our prescription drugs

30 November 2020 - Canada is putting the kibosh on President Donald Trump's efforts to lower drug prices by importing ...

Read more →